References
- Koene RJ, Prizment AE, Blaes A, et al. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133:1104–1114. doi:10.1161/circulationaha.115.020406
- Tsimikas S, Mallat Z, Talmud PJ, et al. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events. J Am Coll Cardiol. 2010;56(12):946–955. doi:10.1016/j.jacc.2010.04.048
- Zhang W, Speiser JL, Ye F, et al. High-sensitivity C-reactive protein modifies the cardiovascular risk of lipoprotein(a): multi-ethnic study of; atherosclerosis. J Am Coll Cardiol. 2021;78:1083–1094. doi:10.1016/j.jacc.2021.07.016
- National Center for Health Statistics (US). Plan and operation of the third national health and nutrition examination survey, 1988–94. Series 1: programs and collection procedures. In: Vital and Health Statistics Ser 1, Programs and Collection Procedures. National Center for Health Statistics (US); 1994:1–407.
- Leiva O, AbdelHameid D, Connors JM, et al. Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: cardio Oncology State-of-The-Art Review. JACC CardioOncol. 2021;3(5):619–634. doi:10.1016/j.jaccao.2021.08.011